Epicardial Fat Thickness as Cardiovascular Risk Factor and Therapeutic Target in Patients with Rheumatoid Arthritis Treated with Biological and Nonbiological Therapies
Table 2
Biochemical variables and left ventricular mass of the control group, the group of RA subjects treated with nonbiological DMARDs, and those treated with biological DMARDs.
Variable
Control group = 16
RA nonbiological DMARDs = 16
RA biological DMARDs = 18
Glucose (mg/dL)
94.87 ± 8.87
91.43 ± 16.07
86.22 ± 10.37
Basal insulin (mU/mL)
12.25 ± 6.85
13.09 ± 7.92
13.32 ± 6.32
Total cholesterol (mg/dL)
197.43 ± 50.23
212.37 ± 48.54
197.55 ± 54.70
HDL-C (mg/dL)
50.53 ± 14.52
51.91 ± 15.41
55.49 ± 13.47
LDL-C (mg/dL)
121.24 ± 47.83
130.81 ± 36.78
118.55 ± 41.86
Non-HDL-C (mg/dL)
146.90 ± 44.60
160.45 ± 47.45
142.06 ± 49.90
Triglycerides (mg/dL)
140.62 ± 54.33
148.18 ± 84.75
117.66 ± 64.08
Tg/HDL-C ratio
2.90 ± 1.19
3.11 ± 2.26
2.24 ± 1.49
hs-CRP (mg/L)
1.61 ± 0.82
2.79 ± 1.51*
2.76 ± 1.94*
LVM (g/m2)
84.62 ± 26.07
130.44 ± 25.77**
120.94 ± 29.53**
Continuous variables are presented as . HDL-C: high-density lipoprotein, LDL-C: low-density lipoprotein, Tg: triglycerides, hs-CRP: high-sensitivity C-reactive protein, and LVM: left ventricular mass. versus control group. versus control group.
